Squarepoint Ops LLC Rezolute, Inc. Transaction History

Squarepoint Ops LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Aug 27, 2025	BUY	$2.73 - $5.57 $415,915 - $848,589	152,350 New	152,350 $441,000
Q1 2025 May 15, 2025	BUY	$2.73 - $5.57 $364,040 - $742,748	133,348 Added 701.76%	152,350 $441,000
Q4 2024 Feb 14, 2025	SELL	$4.08 - $5.96 $16,238 - $23,720	-3,980 Reduced 17.32%	19,002 $90,000
Q3 2024 Nov 14, 2024	BUY	$4.13 - $5.31 $94,915 - $122,034	22,982 New	22,982 $111,000

124

68.9M

1.01M

57.2K

Ticker RZLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,600
Market Cap $385M
Description
Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.